Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Maintains Outperform on Elastic, Lowers Price Target to $90

Oppenheimer analyst Ittai Kidron maintains Elastic (NYSE:ESTC) with a Outperform and lowers the price target from $110 to $90.
byBenzinga Newsdesk
December 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Ittai Kidron maintains Elastic (NYSE:ESTC) with a Outperform and lowers the price target from $110 to $90.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Revolution Medicines Announces Publications On The Discovery And Preclinical Profile Of Representative Of A New Class Of RAS(ON) Multi-Selective Inhibitors Designed To Block Full Spectrum Of Oncogenic RAS(ON) Proteins

By Benzinga Newsdesk
April 8, 11:38 AM
Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that exhibits unprecedented anti-tumor activity in preclinical models of

RVMD